NO952261D0 - Antacidiumforbindelser og fremgangsmåte for fremstilling derav - Google Patents

Antacidiumforbindelser og fremgangsmåte for fremstilling derav

Info

Publication number
NO952261D0
NO952261D0 NO952261A NO952261A NO952261D0 NO 952261 D0 NO952261 D0 NO 952261D0 NO 952261 A NO952261 A NO 952261A NO 952261 A NO952261 A NO 952261A NO 952261 D0 NO952261 D0 NO 952261D0
Authority
NO
Norway
Prior art keywords
antacidium
compounds
preparation
methods
antacidium compounds
Prior art date
Application number
NO952261A
Other languages
English (en)
Norwegian (no)
Other versions
NO952261L (no
Inventor
Gary G Liversidge
Gregory L Mcintire
Original Assignee
Eastman Kodak Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eastman Kodak Co filed Critical Eastman Kodak Co
Publication of NO952261L publication Critical patent/NO952261L/no
Publication of NO952261D0 publication Critical patent/NO952261D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO952261A 1992-12-11 1995-06-08 Antacidiumforbindelser og fremgangsmåte for fremstilling derav NO952261D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98929692A 1992-12-11 1992-12-11
PCT/US1993/011720 WO1994013304A2 (en) 1992-12-11 1993-12-03 Antacid composition and method of production

Publications (2)

Publication Number Publication Date
NO952261L NO952261L (no) 1995-06-08
NO952261D0 true NO952261D0 (no) 1995-06-08

Family

ID=25534976

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952261A NO952261D0 (no) 1992-12-11 1995-06-08 Antacidiumforbindelser og fremgangsmåte for fremstilling derav

Country Status (10)

Country Link
EP (1) EP0673253A1 (ja)
JP (1) JPH08504442A (ja)
KR (1) KR950703982A (ja)
AU (1) AU6390894A (ja)
CA (1) CA2150383A1 (ja)
CZ (1) CZ148695A3 (ja)
FI (1) FI952859A (ja)
NO (1) NO952261D0 (ja)
SK (1) SK76595A3 (ja)
WO (1) WO1994013304A2 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ271410A (en) * 1993-08-24 1997-02-24 Kappa Pharmaceuticals Ltd Use in a medicament of a chemical agent selected from ions of a group ii or group iii metal or salt thereof
ES2297831T3 (es) 1994-05-09 2008-05-01 Oxford Biomedica (Uk) Limited Vectores retroviricos que presentan una tasa de recombinacion reducida.
US5874112A (en) * 1997-03-31 1999-02-23 Mcneil Ppc-Inc. Translucent antacid suspension
AU2002951438A0 (en) * 2002-09-17 2002-10-03 Nauveau Technology Investments Ltd Methods and compositions for treatment of excess stomach acid in mammals
RU2013148719A (ru) * 2013-10-31 2015-05-10 Геннадий Гильфанович Галимов Композиция на основе гидроксоалюмината хлорида магния, содержащая гидроксид магния, в качестве терапевтического препарата
JPWO2016104367A1 (ja) * 2014-12-22 2017-09-28 株式会社Ｌｔｔバイオファーマ 機能性ディスペプシア治療薬

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3843778A (en) * 1970-04-28 1974-10-22 Rorer Inc William H Antacids
US4271142A (en) * 1979-06-18 1981-06-02 Life Savers, Inc. Portable liquid antacids
FR2512344A1 (fr) * 1981-09-08 1983-03-11 Af Aplicaciones Far Lab Procede de fabrication d'une suspension stable d'hydroxyde d'alumine et/ou d'hydroxyde de magnesie comme agent actif des antacida

Also Published As

Publication number Publication date
KR950703982A (ko) 1995-11-17
AU6390894A (en) 1994-07-04
WO1994013304A3 (en) 1994-09-01
FI952859A0 (fi) 1995-06-09
CZ148695A3 (en) 1995-12-13
CA2150383A1 (en) 1994-06-23
NO952261L (no) 1995-06-08
JPH08504442A (ja) 1996-05-14
SK76595A3 (en) 1997-01-08
FI952859A (fi) 1995-06-09
WO1994013304A2 (en) 1994-06-23
EP0673253A1 (en) 1995-09-27

Similar Documents

Publication Publication Date Title
TR25002A (tr) Kristalik natrinyumsilikatlarin hazirlanis yöntemi
DK42093D0 (da) Administrationsmetode
NO944164D0 (no) Fremgangsmåte for fremstilling og anvendelse av en HCl-adsorbent
IL98618A0 (en) Improved ointment base and method of use
NO934878D0 (no) Herde-aktiverte sementblandinger og fremgangsmaater
DK10289D0 (da) Fremgangsmaade og praeparater til forebyggelse af ulcus
MX9200273A (es) Nuevos compuestos de sulfonilureas y procedimientopara su obtencion
NO972477D0 (no) Meso-mono-jod substituerte tetramakrocykliske forbindelser og fremgangsmåter for fremstilling og anvendelse
DK0635004T3 (da) 4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf
NO306932B1 (no) Oljeaktig preparat og fremgangsmåte for fremstilling av dette
NO940027L (no) Fremgangsmaate for fremstilling av derivater av B-fenylisorerin og derivatenes anvendelse
NO304890B1 (no) Farmas°ytiske forbindelser og farmas°ytiske preparater
NO932860D0 (no) Fremgangsmaate for fremstilling av kalsium-l-askorbat-2-fosfat
DK0512547T3 (da) Smertekontrollerende præparat og fremgangsmåde til fremstilling deraf
NO952261D0 (no) Antacidiumforbindelser og fremgangsmåte for fremstilling derav
BR9306359A (pt) Azocorantes aplicação do azocorante e modificação cristalina
NO940634L (no) Antiulcusmiddel og fremgangsmåte for fremstilling derav
NO934293D0 (no) Fremgangsm}ter og streptomycesstamme for fremstilling av antiparastiske forbindelser
NO932375D0 (no) Amider avledet fra 3-aminoetyl og fremgangsmaate for deresfremstilling
DK0390762T3 (da) Hidtil ukendte bronchospasmolytiske forbindelser og fremgangsmåde til fremstilling heraf
DK0425029T3 (da) Krystallinske aluminophosphater og dermed beslægtede forbindelser
NO942531D0 (no) Fremgangsmåte for fremstilling av 3-acylöstratriener og acylbenzener
FI923360A (fi) Foerfarande foer framstaellning av dimetylacetoacetamid
KR950700319A (ko) 3-카르보닐안드로스타디엔 17-카르복스아미드를 제조하는 방법(Process of preparing 3-carbonylandrostadiene 17-carboxamides)
KR950700320A (ko) 3-아실안드로스타디엔을 제조하는 방법(Process of preparing 3-acylandrostadienes)